Giulia Boccalini
Prato, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Single-cell transcriptomics reveals biomarker heterogeneity linked to CDK4/6 Inhibitor resistance in breast cancer cell lines.
Journal: NPJ breast cancer
Published: February 27, 2025
An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06).
Journal: Therapeutic advances in medical oncology
Published: February 01, 2019
Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor-positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT).
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 12, 2018
ddSeeker: a tool for processing Bio-Rad ddSEQ single cell RNA-seq data.
Journal: BMC genomics
Published: July 06, 2018
Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of Response.
Mechanisms of Resistance to CDK4/6 Inhibitors in Breast Cancer and Potential Biomarkers of Response.
Journal: Breast care (Basel, Switzerland)
Published: December 14, 2017
Model lipid bilayers mimic non-specific interactions of gold nanoparticles with macrophage plasma membranes.
Journal: Journal of colloid and interface science
Published: December 06, 2017
Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy.
Journal: Oncotarget
Published: October 15, 2017
Relaxin induces up-regulation of ADAM10 metalloprotease in RXFP1-expressing cells by PI3K/AKT signaling.
Journal: Molecular and cellular endocrinology
Published: July 25, 2017
Methylene blue-containing liposomes as new photodynamic anti-bacterial agents.
Journal: Journal of materials chemistry. B
Published: April 21, 2017
Protection from Cigarette Smoke-Induced Lung Dysfunction and Damage by H2 Relaxin (Serelaxin).
Journal: The Journal of pharmacology and experimental therapeutics
Published: January 19, 2016
HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.
Journal: Journal of cellular and molecular medicine
Published: December 21, 2015
Last Updated: 09/26/2026